CGI

• Cisplatin
• Ifosfamide
• Gemcitabine

Name

Cisplatin

Alternate Names

Cis-Platin

Cis-Platinum II#

Cisplatino (Spanish)

Cisplatinum

Cisplatyl

Neoplatin

Peyrone's chloride

Platinex

Platinol

Platinol-AQ

Platinol-AQ VHA Plus

Platinum

Abbreviations

CACP

CDDP

Cis-DDP

CPD

CPDC

CPDD

CPPD

DDP

Category

Chemotherapy

Subcategory

Alkylating agent

Platinum analog

NSC Number

119875

Primary Site

Bladder

ovarian

testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded

Name

Ifosfamide

Alternate Names

A-4942

Asta Z-4942

Cyfos#

Holoxan 1000

Ifex

Ifosfamid

Ifoxan

Iphosphamid

Iphosphamide

Iso-endoxan

Isofosfamide

Isophos-phamide

Isophosphamide

Mitoxana

MJF 9325

MJF-9325

Naxamide#

Z4942

Abbreviations

IFX

IPP

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

109724

Primary Site

Bladder

Cervical cancer

Ewing sarcoma

Head and Neck

Hodgkin lymphoma

Non-Hodgkin lymphoma

Non-small cell and small cell lung cancer

Soft tissue sarcoma, osteogenic sarcoma

Testicular cancer

Histology

None

Remarks

Antineoplastic with alkylating activity. FDA approved.

Coding

This drug should be coded

Name

Gemcitabine

Alternate Names

Gemcitabine Hydrochloride

Gemzar

LY 188011

LY-188011

LY188011 hydrochloride

Gemcitabine HCL

Abbreviations

None

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

613327

Primary Site

Bladder

Breast

non-small cell lung

ovarian

pancreatic cancer

Soft Tissue Sarcoma

Histology

None

Remarks

FDA approved for breast. ovarian, pancreas, NSC lung
Gemcitabine HCL is given intravesically as treatment for bladder tumors. Code as chemotherapy.

Coding

This drug should be coded